During the past decade, North Carolina Children's Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North Carolina Children's Hospital" #1 sponsor was "University of North Carolina, Chapel Hill" with 3 trials, followed by "Chris Goss" with 1 trials sponsored, "Columbia University" with 1 trials sponsored, "Duke University" with 1 trials sponsored and "Jubilant DraxImage Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North Carolina Children's Hospital" #1 collaborator was "Baylor College of Medicine" with 1 trials as a collaborator, "Boston Children's Hospital" with 1 trials as a collaborator, "CF Therapeutics Development Network Coordinating Center" with 1 trials as a collaborator, "Children's Healthcare of Atlanta" with 1 trials as a collaborator and "Children's Hospital Medical Center, Cincinnati" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "North Carolina Children's Hospital" are "Apnea of Prematurity" (1 trials), "Asthma" (1 trials), "COVID-19" (1 trials), "Caffeine" (1 trials) and "Critical Illness" (1 trials). Many other conditions were trialed in "North Carolina Children's Hospital" in a lesser frequency.

Most popular intervention types in "North Carolina Children's Hospital" are "Drug" (5 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Caffeine" (1 trials), "DUPIXENT®" (1 trials), "I-131 MIBG" (1 trials), "Intranasal dexmedetomidine" (1 trials) and "Language toolkit" (1 trials). Other intervention names were less common.

The vast majority of trials in "North Carolina Children's Hospital" are 9 trials for "All" genders.

Currently, there are NaN active trials in "North Carolina Children's Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in North Carolina Children's Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in North Carolina Children's Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

North Carolina Children's Hospital has several departments that took part in Clinical trials: "North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology" - 3 trials, "UNC Children's Raleigh" - 2 trials, "NC Children's Specialty Clinic, 4414 Lake Boone Trail, Suite 505" - 2 trials